Outcomes from an outpatient smoking-cessation clinic

Pharmacotherapy

Volumn 25, Issue 2, 2005, Pages 279-288

  Roth, Mary T ^a   Andrus, Miranda R ^b   Westman, Eric C ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b AUBURN UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bupropion; Smoking cessation; Smoking cessation products; Tobacco dependence

Indexed keywords

AMFEBUTAMONE; NICOTINE;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE EXACERBATION; DIZZINESS; DROWSINESS; DRUG ERUPTION; DRUG INDUCED HEADACHE; FEMALE; FOLLOW UP; HEALTH PROGRAM; HICCUP; HUMAN; INHALER; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; OUTCOMES RESEARCH; OUTPATIENT DEPARTMENT; PATIENT COUNSELING; PATIENT MONITORING; PATIENT REFERRAL; PHARYNGITIS; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIMARY MEDICAL CARE; PRURITUS; SEXUAL DYSFUNCTION; SIDE EFFECT; SMOKING CESSATION; STATISTICAL SIGNIFICANCE; SUSTAINED DRUG RELEASE; THORAX PAIN; TOBACCO DEPENDENCE; TRANSDERMAL PATCH; TREMOR; UNITED STATES; VIVID DREAM; WITHDRAWAL SYNDROME;

AMBULATORY CARE FACILITIES; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 13544266279     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.25.2.279.56957     Document Type: Article

References (25)

1. Office of Disease Prevention and Health Promotion, U.S. Department of Health and Human Services. Healthy people 2010 goals and objectives. Available from http://www.health.gov/healthypeople/document/html/volume2/27tobacco.htm. Accessed November 22, 2004.
2. Centers for Disease Control and Prevention. Cigarette smoking among adults: United States, 2001. Available from: http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5303a1.htm. Accessed November 22, 2004.
3. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. A clinical practice guideline for treating tobacco use and dependence: a U.S. Public Health Service report. JAMA 2000;283:3244-54.
4. Rigotti NA. Treatment of tobacco use and dependence. N Engl J Med 2002;346:506-12.
5. Hughes JR, Goldstein MG, Hurt RD, et al. Recent advances in the pharmacotherapy of smoking. JAMA 1999;281:72-6.
6. Hurt RD, Sachs DPL, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997;337:1195-202.
7. Hajek P, West R, Foulds J, et al. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch Intern Med 1999;159:2033-8.
8. Sweeney CT, Fant RV, Fagerstrom KO, et al. Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability. CNS Drugs 2001;15:453-67.
9. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999;340:685-91.
10. Jamerson BD, Nides M, Jorenby DE, et al. Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, or placebo. Clin Ther 2001;23:744-52.
11. Bohadana A, Nilsson F, Rasmussen T, et al. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 2000;160:3128-34.
12. Blondal T, Gudmundsson LJ, Olafsdottir I, et al. Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six-year follow up. BMJ 1999;318:285-8.
13. DiClemente CC, Prochaska JO, Faithhurst SK, et al. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol 1991;59:295-304.
14. Wongwiwatthananukit S, Jack HM, Popovich NG. Smoking cessation. Part 1: an overview. J Am Pharm Assoc 1998;38:58-70.
15. Roth MT, Westman EC. Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program. Pharmacotherapy 2001;21:636-41.
16. Hurt RD, Dale LC, Offord KP, et al. Serum nicotine and cotinine levels during nicotine patch therapy. Clin Pharmacol Ther 1993;54:98-106.
17. Hurt RD, Dale RC, Fredrickson PA, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up: one year outcome and percentage of nicotine replacement. JAMA 1994;271:595-600.
18. Lowell DC, Hurt RD, Offord KP, et al. High-dose nicotine patch therapy. JAMA 1995;274:1353-8.
19. Tonnesen P, Paoletti P, Gustavsson G, et al. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Eur Respir J 1999;13:238-46.
20. Hughes JR, Lesmes GR, Hatsukami DK, et al. Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tobacco Res 1999;1:169-74.
21. Killen JD, Fortmann SP, Davis L, Strausberg L, Varady A. Do heavy smokers benefit from higher dose nicotine patch therapy? Exp Clin Psychopharmacol 1999;7:226-33.
22. Swan GE, Jack LM, Curry S, et al. Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome. Nicotine Tobacco Res 2003;5:911-21.
23. Sutton S. Back to the drawing board? A review of applications of the transtheoretical model to substance abuse. Addiction 2001;96:175-86.
24. West R. ABC of smoking cessation: assessment of dependence and motivation to stop smoking. BMJ 2004;328:338-9.
25. Kozlowski LT, Porter CQ, Orleans CT, Pope MA, Heatherton T. Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HIS. Drug Alcohol Depend 1994;34:211-16.